Imperva Inc. (NYSE:IMPV)‘s stock had its “hold” rating restated by analysts at Deutsche Bank AG in a research report issued to clients and investors on Saturday.
A number of other analysts also recently commented on the stock. Pacific Crest downgraded shares of Imperva from an “overweight” rating to a “sector weight” rating and dropped their target price for the stock from $47.00 to $30.00 in a report on Tuesday, August 30th. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Imperva in a report on Tuesday, July 12th. Nomura reiterated a “buy” rating and issued a $55.00 target price (down from $60.00) on shares of Imperva in a report on Friday, July 15th. Imperial Capital reiterated an “outperform” rating and issued a $50.00 target price (down from $55.00) on shares of Imperva in a report on Monday, August 8th. Finally, Morgan Stanley set a $35.00 target price on shares of Imperva and gave the stock a “sell” rating in a research report on Friday, August 5th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $52.33.
Imperva (NYSE:IMPV) opened at 49.03 on Friday. The stock’s market cap is $1.60 billion. Imperva has a 1-year low of $31.11 and a 1-year high of $77.99. The firm’s 50-day moving average is $48.31 and its 200-day moving average is $44.83.
Imperva (NYSE:IMPV) last released its earnings results on Thursday, August 4th. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by $0.19. Imperva had a negative return on equity of 25.68% and a negative net margin of 23.75%. The business earned $57.87 million during the quarter, compared to the consensus estimate of $66.06 million. During the same quarter in the previous year, the firm earned ($0.08) earnings per share. The firm’s revenue for the quarter was up 8.2% compared to the same quarter last year. On average, analysts forecast that Imperva will post ($0.80) EPS for the current year.
In related news, SVP Mark E. Kraynak sold 5,582 shares of the company’s stock in a transaction on Friday, September 23rd. The shares were sold at an average price of $51.00, for a total transaction of $284,682.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Amichai Shulman sold 937 shares of the company’s stock in a transaction on Friday, September 23rd. The shares were sold at an average price of $51.00, for a total transaction of $47,787.00. Following the transaction, the insider now owns 95,084 shares of the company’s stock, valued at $4,849,284. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.
A number of institutional investors have recently added to or reduced their stakes in IMPV. Parametrica Management Ltd bought a new position in Imperva during the second quarter valued at approximately $396,000. Eagle Asset Management Inc. boosted its position in Imperva by 3.1% in the second quarter. Eagle Asset Management Inc. now owns 1,338,055 shares of the company’s stock valued at $57,549,000 after buying an additional 40,709 shares during the last quarter. Fisher Asset Management LLC bought a new position in Imperva during the second quarter valued at approximately $5,942,000. Jacobs Levy Equity Management Inc. boosted its position in Imperva by 198.0% in the first quarter. Jacobs Levy Equity Management Inc. now owns 54,560 shares of the company’s stock valued at $2,755,000 after buying an additional 36,250 shares during the last quarter. Finally, Granahan Investment Management Inc. MA boosted its position in Imperva by 28.7% in the first quarter. Granahan Investment Management Inc. MA now owns 414,030 shares of the company’s stock valued at $20,909,000 after buying an additional 92,250 shares during the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.